Single-use Bronchoscopes Market

Market Study on Single-use Bronchoscopes: Worldwide Product Sales Led by Bronchoscopy Suites

Single-use Bronchoscopes Market Segmented By Product (Large, Regular, Slim, Ultra-slim, Extra-large), Regular-sized single-use bronchoscopes accounted for 34.8% of the global market share.

Industry: Healthcare

Published Date: April-2023

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 286

Report ID: PMRREP25891

Report Price

$ 4900*

Buy Now

Single-use Bronchoscopes Market Outlook (2023 to 2033)

The global single-use bronchoscopes market expanded at a CAGR of 16.7% from 2018 to 2022 and stood at US$ 330.4 million in 2022. Worldwide sales of single-use bronchoscopes are forecasted to increase at a CAGR of 23.6% and reach a market valuation of US$ 3.26 billion by the end of 2033.

  • As per this new analysis by Persistence Market Research, COPD indication held a market share of 29.5% in 2022.
  • Sales of single-use bronchoscopes accounted for 28.2% share of the global single-use endoscopes market in 2022.

Bronchoscopy is an important diagnostic tool for determining the cause of pulmonary radiographic anomalies. It has diagnostic applications in detecting infections, neoplasms, and hemoptysis, and therapeutic purposes such as airway secretion clearance, mucus plugging and alleviation of airway obstructions, and airway management.

Demand for single-use bronchoscopes is expanding as a result of several factors, including the increasing incidence of lung cancer, chronic obstructive pulmonary disease (COPD), and increased research and development activities in the field of bronchoscopy.

Single-use flexible bronchoscopes are in high demand because they are supplied as sterile devices, reducing the risk of infection transmission and cross-contamination when compared to reusable flexible bronchoscopes. The market is being driven by the shift from conventional open surgeries to minimally invasive procedures for diagnostic and therapeutic purposes, as well as cost-effective single-use bronchoscopes.

Leading market players are creating novel products with improved technology in areas such as scope quality, imaging quality, maneuverability, handling, tool interaction, and overall evaluation. Some companies are actively expanding their product portfolio by introducing different single-use or disposable bronchoscopes.

The market is being hindered by the negative economic and environmental impacts of these products, which generate more waste in landfills compared to reusable bronchoscopes. The creation of biodegradable single-use items and the discovery of recycling solutions can open up attractive market opportunities.

Single-use Bronchoscopes Market Size (2023)

US$ 392 Million

Projected Market Value (2033)

US$ 3.26 Billion

Global Market Growth Rate (2023 to 2033)

23.6% CAGR

Market Share of Top 5 Countries

51.3%

What are the Factors Influencing the Demand Growth for Single-use Bronchoscopes?

“Rise in Prevalence of Lung Cancer and Increased Need for Acquired Infection Prevention”

The rising incidence of lung cancer is responsible for the increase in demand for single-use bronchoscopes.

  • According to the World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. It ranks as the second most frequent cancer in women and the most common cancer in men.
  • In 2020, there were over 2.2 million new cases of lung cancer. To safely perform procedures like bronchoalveolar lavage (BAL) and simple airway inspection, single-use bronchoscopes are being utilized. These are reliable and cost-effective substitutes for conventional, reusable bronchoscopes when performing BAL procedures.

COVID-19 hastened the production of single-use bronchoscopes as both healthcare workers and patients became more conscious of infection control and patient safety strategies.

The heightened focus on infection prevention due to the global pandemic has resulted in increased attention towards using single-use bronchoscopes for ensuring patient health and healthcare worker safety. This has led several medical organizations and professionals across the globe, including the United States, to advocate for the adoption of these bronchoscopes whenever bronchoscopies are necessary.

Increased awareness about infection transmissions as well as a focus on hygiene during endoscopic procedures is boosting market growth.

What are the Hindrances to the Adoption of Single-use Bronchoscopes?

“Environmental Hazards Associated with Disposable Non-biodegradable Single-use Microscopes”

The utilization of disposable bronchoscopes may be limited in certain healthcare environments as reusable bronchoscopes are often employed for a broader range of procedures compared to disposable ones.

For instance, complex endoscopic surgeries may require specialized equipment that cannot be used with disposable bronchoscopes, reducing their demand in several diagnostic and therapeutic procedures. The amount of landfill waste produced by disposable bronchoscopes is another factor restraining their market growth.

Country-wise Insights

What Makes the United States a Highly Lucrative Market for Single-use Bronchoscope Manufacturers?

"FDA Advisory Supporting Use of Single-use Bronchoscopes for Treating Lung Disorders”

The United States accounted for 30.2% share of the global single-use bronchoscopes market in 2022.

  • In the United States alone, there are about 500,000 bronchoscopies carried out each year.
  • The FDA is providing current information on reports of negative incidents related to medical devices, specifically bronchoscopes, along with recommendations for healthcare professionals. Despite the potential risk of infection, the FDA asserts that the benefits of undergoing a bronchoscopy generally outweigh the risks for most patients.
  • In June 2021, the FDA advised that doctors should use single-use bronchoscopes when treating COVID-19 patients and other illnesses where there is a higher risk of infection transmission.

What is the Demand Outlook for Single-use Bronchoscopes in China?

“Increasing Utilization of Single-use Bronchoscopes among Expanding Geriatric Population”

China held 7.9% share of the global market in 2022.

One of the primary drivers for the adoption and promotion of minimally invasive medical devices in China is the growing number of elderly individuals in the population. These devices are aimed at alleviating pain and reducing the risk of infection. The incidence of lung cancer is on the rise among the Chinese population.

  • According to a study published in the Chinese Medical Journal in 2022, it has been projected that there will be around 4,820,000 cases of cancer in China, with lung cancer being the most prevalent form.

The availability of disposable bronchoscopes has contributed to the rise in bronchoscopy procedures, even among elderly patients who experience minimal discomfort. The government is demonstrating its concern by approving the use of single-use bronchoscope devices in the Chinese market.

How is the Demand for Single-use Bronchoscopes Shaping Up in Germany?

“Rising Prevalence of Healthcare-associated Infections”

Germany occupied 4.3% share of the global market in 2022.

Demand for single-use bronchoscopes is steadily increasing in Germany due to the growing burden of chronic diseases, lung issues, and the need for infection prevention measures. To reduce the risk of cross-contamination associated with reusable endoscopes, manufacturers and research groups are collaborating to develop technologically advanced products. Medical device manufacturers are also partnering with technical universities to leverage German manufacturing advancements.

  • An example of this trend is the recent announcement by the German Design Council that Zsquare, a company specializing in the development of high-performance single-use endoscopes, has won the German Innovation Awards 2022. These awards acknowledge products and services that excel above their competitors in all industrial sectors, based on their user-centric approach and added value.

Category-wise Insights

Which Type of Single-use Bronchoscope is Used Extensively?

“High Demand for Regular-sized Single-Use Bronchoscopes Due to Rising Lung Disorders among Teens”

In 2022, regular-sized single-use bronchoscopes accounted for 34.8% of the global market share.

Healthcare professionals prefer this size due to the high prevalence of chronic lung disorders among adults and teens. These products are more widely available compared to other sizes, further contributing to their dominance in the market. As a result, the demand for regular-sized single-use bronchoscopes is expected to grow steadily throughout the forecast period.

Which Usage-based Segment Accounts for High Sales of Single-use Bronchoscopes?

“Availability of Qualified Diagnostic Personnel in Bronchoscopy Suites Leading to Increased Utilization of Single-Use Bronchoscopes”

Bronchoscopy suites held 44.5% share of the global single-use bronchoscopes market in 2022.

Bronchoscopy procedures are best suited to a controlled environment, such as a bronchoscopy suite. Patients prefer this segment due to the favorable room designs, modern and technologically advanced procedures, and the availability of qualified diagnostic personnel.

Which Indication is Mostly Treated with Single-use Bronchoscopes?

“Increasing Prevalence of COPD Worldwide”

Chronic obstructive pulmonary disease (COPD) occupied 29.5% share of the single-use bronchoscopes market in 2022.

  • According to the World Health Organization (WHO), in 2019, chronic obstructive pulmonary disease (COPD) was responsible for 3.23 million deaths, making it the third most common cause of death worldwide. Approximately 90% of COPD fatalities in low- and middle-income countries occur in people under the age of 70. Over 70% of COPD cases in high-income countries are attributed to tobacco use, according to WHO.

Increased burden of this disease globally has led to the higher adoption of bronchoscopy procedures. As COPD is one of the leading risk factors for lung cancer, single-use bronchoscopes help control infection prevention.

Competition Landscape

Leading companies in the global single-use bronchoscopes market are constantly working to innovate and launch products in the market to improve their market share.

  • Olympus announced the clearance of its H-SteriScopeTM Single-use Bronchoscopes on April 30, 2021. These bronchoscopes are designed for use in advanced diagnostic and therapeutic procedures.
  • The Ambu® aScopeTM 5 Broncho family of single-use, sterile bronchoscopes was granted regulatory approval under 510(k) by the U.S. Food and Drug Administration (FDA) on July 27, 2022.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in this market, which are available in the full report.

Single-use Bronchoscopes Industry Report Scope

Attribute

Details

Forecast Period

2023 to 2033

Historical Data Available for

2018 to 2022

Market Analysis

  • US$ Million/Billion for Value
  • Units for Volume

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordic Countries
  • Poland
  • Hungary
  • Romania
  • Czech Republic
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Vietnam
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Türkiye
  • GCC Countries
  • Kingdom of Saudi Arabia
  • Israel
  • North African Countries
  • South Africa
  • Central Asia
  • Russia and Belarus
  • Balkan & Baltic Countries

Key Market Segments Covered

  • Product
  • Usage
  • Indication
  • End User
  • Region

Key Companies Covered

  • AMBU A/S
  • Boston Scientific Corporation
  • Fujifilm Holdings Corporation
  • Karl Storz GmbH & Co. KG
  • NeoScope Inc.
  • Olympus Corporation
  • Boston Scientific Corporation
  • PENTAX Medical
  • Karl Storz SE & Co.
  • Endoso Life
  • Innovex Medical Co., Ltd.
  • Hunan Vathin Medical Instrument Co., Ltd.
  • Zhejiang Geyi Medical Instrument Co., Ltd.
  • Others

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments of Single-use Bronchoscopes Industry Research

By Product:

  • Large
  • Regular
  • Slim
  • Ultra-slim
  • Extra-large

By Usage:

  • Bedside Procedures
  • Emergency Rooms
  • Bronchoscopy Suites
  • ICUs

By Indication:

  • Lung Cancer
  • Pulmonary Infections
  • Interstitial Lung Disease
  • Tuberculosis
  • COPD
  • Cystic Fibrosis

By End User:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Diagnostic Centers

Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East and Africa

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • AMBU A/S
  • Boston Scientific Corporation
  • Fujifilm Holdings Corporation
  • Karl Storz GmbH & Co. KG
  • NeoScope Inc.
  • Olympus Corporation
  • Boston Scientific Corporation
  • PENTAX Medical
  • Karl Storz SE & Co.
  • Endoso Life
  • Innovex Medical Co.,Ltd.
  • Hunan Vathin Medical Instrument Co., Ltd.
  • Zhejiang Geyi Medical Instrument Co.,Ltd

Frequently Asked Questions

The global single-use bronchoscopes market was valued at US$ 330.4 million in 2022.

Sales of single-use bronchoscopes increased at 16.7% CAGR from 2018 to 2022.

The U.S., China, Japan, India, and Germany collectively held 51.3% share of the global market in 2022.

The U.S. accounted for 30.2% share of the global market in 2022.

China accounted for 7.9% of the global single-use bronchoscopes market in 2022.

Germany accounted for 4.3% share of the global market in 2022.

Hospitals accounted for a market share of 48.2% in 2022.

Sales of single-use bronchoscopes are valued at US$ 392 million in 2023.

Demand for single-use bronchoscopes is anticipated to reach US$ 3.26 billion by the end of 2033.

Sales of single-use bronchoscopes are projected to increase at a CAGR of 23.6% through 2033.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate